Stevanato Group S.p.A., a global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology and life science industries, has inaugurated its Cisterna di Latina plant.
 
Located just a few kilometers from the Group’s first plant in Latina, the new site covers an area of 65,000 square meters and employs around 200 people. The facility started commercial production in Q4 2023 and houses advanced production lines developed by Stevanato Group for the production of EZ-fill pre-sterilized syringes with the aim of responding to the modern challenges of the European market. Furthermore, the Company plans to implement production with EZ-fill pre-sterilized cartridges between 2025 and 2026 as the site becomes fully operational.
 
Franco Stevanato, Executive Chairman and CEO of Stevanato Group said: “We are proud to have reached this new milestone, which will allow us to strategically expand in one of the main pharmaceutical hubs in our country. With the new plant in Cisterna di Latina, we are increasing  production capacity, helping to reinforce the supply chain for Europe and furthering our commitment to customers, who increasingly need high-quality drug containment systems, such as our high-value solutions.”
 
The plant in Cisterna di Latina represents one of Stevanato Group’s most significant investments in the last five years. The Cisterna site is the Group’s first to have implemented high-value solutions production outside the Company’s headquarters in Piombino Dese. The next one will be in Fishers, Indiana, U.S.
 
The Cisterna di Latina facility will support global biopharmaceutical partners and customers with an integrated product and service offering, aiming at optimizing the supply chain, reducing overall risk, and improving time to market. The high-value pre-sterilized solutions produced at the site will be ready for filling, enabling customers to outsource some of the primary packaging processing steps and focus exclusively on their core business.